Differential-informed Sample Selection Accelerates Multimodal Contrastive Learning

The remarkable success of contrastive-learning-based multimodal models has been greatly driven by training on ever-larger datasets with expensive compute consumption. Sample selection as an alternative efficient paradigm plays an important direction to accelerate the training process. However, recent advances on sample selection either mostly rely on an oracle model to offline select a high-quality coreset, which is limited in the cold-start scenarios, or focus on online selection based on real-time model predictions, which has not sufficiently or efficiently considered the noisy correspondence. To address this dilemma, we propose a novel Differential-Informed Sample Selection (DISSect) method, which accurately and efficiently discriminates the noisy correspondence for training acceleration. Specifically, we rethink the impact of noisy correspondence on contrastive learning and propose that the differential between the predicted correlation of the current model and that of a historical model is more informative to characterize sample quality. Based on this, we construct a robust differential-based sample selection and analyze its theoretical insights. Extensive experiments on three benchmark datasets and various downstream tasks demonstrate the consistent superiority of DISSect over current state-of-the-art methods. Source code is available at: https://github.com/MediaBrain-SJTU/DISSect.

CXR-LT 2024: A MICCAI challenge on long-tailed, multi-label, and zero-shot disease classification from chest X-ray

The CXR-LT series is a community-driven initiative designed to enhance lung disease classification using chest X-rays (CXR). It tackles challenges in open long-tailed lung disease classification and enhances the measurability of state-of-the-art techniques. The first event, CXR-LT 2023, aimed to achieve these goals by providing high-quality benchmark CXR data for model development and conducting comprehensive evaluations to identify ongoing issues impacting lung disease classification performance. Building on the success of CXR-LT 2023, the CXR-LT 2024 expands the dataset to 377,110 chest X-rays (CXRs) and 45 disease labels, including 19 new rare disease findings. It also introduces a new focus on zero-shot learning to address limitations identified in the previous event. Specifically, CXR-LT 2024 features three tasks: (i) long-tailed classification on a large, noisy test set, (ii) long-tailed classification on a manually annotated "gold standard" subset, and (iii) zero-shot generalization to five previously unseen disease findings. This paper provides an overview of CXR-LT 2024, detailing the data curation process and consolidating state-of-the-art solutions, including the use of multimodal models for rare disease detection, advanced generative approaches to handle noisy labels, and zero-shot learning strategies for unseen diseases. Additionally, the expanded dataset enhances disease coverage to better represent real-world clinical settings, offering a valuable resource for future research. By synthesizing the insights and innovations of participating teams, we aim to advance the development of clinically realistic and generalizable diagnostic models for chest radiography.